NCT01784068
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01784068
Title Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients (ENESTfreedom)
Acronym ENESTfreedom
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | SWE | POL | NLD | ITA | IRL | HUN | GRC | GBR | FRA | ESP | DNK | DEU | BGR | BEL | AUT | ARG

Facility Status City State Zip Country Details
Florida Cancer Specialists Fort Myers Florida 33901 United States Details
Lakes Research Miami Lakes Florida 33014 United States Details
H Lee Moffitt Cancer Center and Research Institute Tampa Florida 33612 United States Details
Cancer Center of Kansas Wichita Kansas 67214-3728 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Memorial Sloan Kettering New York New York 10017 United States Details
Oregon Health Sciences University Portland Oregon 97239 United States Details
Cancer Centers of the Carolinas Greenville South Carolina 29605 United States Details
Tennessee Oncology PLLC Chattanooga Tennessee 37404 United States Details
Community Cancer Trials of Utah Ogden Utah 84405 United States Details
Novartis Investigative Site Buenos Aires C1114AAN Argentina Details
Novartis Investigative Site Graz 8036 Austria Details
Novartis Investigative Site Rankweil A-6830 Austria Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Vienna 1140 Austria Details
Novartis Investigative Site Vienna A-1130 Austria Details
Novartis Investigative Site Sint-Niklaas Oost Vlaanderen 9100 Belgium Details
Novartis Investigative Site Brussels 1090 Belgium Details
Novartis Investigative Site Brussels 1200 Belgium Details
Novartis Investigative Site Charleroi 6000 Belgium Details
Novartis Investigative Site Ghent 9000 Belgium Details
Novartis Investigative Site Kortrijk 8500 Belgium Details
Novartis Investigative Site Liège 4000 Belgium Details
Novartis Investigative Site Varna 9000 Bulgaria Details
Novartis Investigative Site Bogota Cundinamarca 111411 Colombia Details
Novartis Investigative Site Montería 230004 Colombia Details
Novartis Investigative Site Aarhus N 8200 Denmark Details
Novartis Investigative Site Bayonne Bayonne Cedex 64109 France Details
Novartis Investigative Site Saint Priest En Jarez Pays de la Loire Region 42270 France Details
Novartis Investigative Site Bordeaux 33076 France Details
Novartis Investigative Site Brest 29609 France Details
Novartis Investigative Site Corbeil-Essonnes 91100 France Details
Novartis Investigative Site Dunkirk 59240 France Details
Novartis Investigative Site Grenoble 38043 France Details
Novartis Investigative Site Nantes 44093 France Details
Novartis Investigative Site Rouen 76038 France Details
Novartis Investigative Site Strasbourg 67000 France Details
Novartis Investigative Site Strasbourg 67085 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Freiburg im Breisgau Baden-Wurttemberg 79106 Germany Details
Novartis Investigative Site Mannheim Baden-Wurttemberg 68305 Germany Details
Novartis Investigative Site Frankfurt am Main Hesse 60590 Germany Details
Novartis Investigative Site Düsseldorf North Rhine-Westphalia 40225 Germany Details
Novartis Investigative Site Leipzig Saxony 04103 Germany Details
Novartis Investigative Site Lübeck Schleswig-Holstein 23563 Germany Details
Novartis Investigative Site Jena Thuringia 07740 Germany Details
Novartis Investigative Site Aachen 52074 Germany Details
Novartis Investigative Site Bayreuth 95445 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Bonn 53105 Germany Details
Novartis Investigative Site Bottrop 46236 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Düsseldorf 40479 Germany Details
Novartis Investigative Site Goslar 38642 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Hamburg 22417 Germany Details
Novartis Investigative Site Magdeburg 39104 Germany Details
Novartis Investigative Site Mainz 55131 Germany Details
Novartis Investigative Site Stuttgart 70376 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Athens 106 76 Greece Details
Novartis Investigative Site Athens 115 27 Greece Details
Novartis Investigative Site Budapest H-1083 Hungary Details
Novartis Investigative Site Szeged 6720 Hungary Details
Novartis Investigative Site Dublin D03 VX82 Ireland Details
Novartis Investigative Site Galway 12074 Ireland Details
Novartis Investigative Site Ancona AN 60126 Italy Details
Novartis Investigative Site Brescia BS 25123 Italy Details
Novartis Investigative Site Cona FE 44100 Italy Details
Novartis Investigative Site Florence FI 50134 Italy Details
Novartis Investigative Site Genova GE 16132 Italy Details
Novartis Investigative Site Nuoro NU 08100 Italy Details
Novartis Investigative Site Perugia PG 06129 Italy Details
Novartis Investigative Site Reggio Calabria RC 89100 Italy Details
Novartis Investigative Site Roma RM 00161 Italy Details
Novartis Investigative Site Orbassano TO 10043 Italy Details
Novartis Investigative Site Terni TR 05100 Italy Details
Novartis Investigative Site Napoli 80132 Italy Details
Novartis Investigative Site Novara 28100 Italy Details
Novartis Investigative Site Kashiwa Chiba 277-8567 Japan Details
Novartis Investigative Site Sapporo Hokkaido 060 8648 Japan Details
Novartis Investigative Site Sagamihara Kanagawa 252-0375 Japan Details
Novartis Investigative Site Ōsaka-sayama Osaka 589 8511 Japan Details
Novartis Investigative Site Suita Osaka 565 0871 Japan Details
Novartis Investigative Site Saga Saga-ken 849-8501 Japan Details
Novartis Investigative Site Kawagoe Saitama 350 8550 Japan Details
Novartis Investigative Site Shimotsuga Gun Tochigi 321-0293 Japan Details
Novartis Investigative Site Bunkyo-ku Tokyo 113-8519 Japan Details
Novartis Investigative Site Shinjuku Ku Tokyo 160-0023 Japan Details
Novartis Investigative Site Akita 010-8543 Japan Details
Novartis Investigative Site Kumamoto 860-8556 Japan Details
Novartis Investigative Site Groningen 9713 GZ Netherlands Details
Novartis Investigative Site Gdansk 80-952 Poland Details
Novartis Investigative Site Warsaw 02 106 Poland Details
Novartis Investigative Site Terrassa Catalonia 08221 Spain Details
Novartis Investigative Site Ourense Galicia 32005 Spain Details
Novartis Investigative Site Pamplona Navarre 31008 Spain Details
Novartis Investigative Site Oviedo Principality of Asturias 33011 Spain Details
Novartis Investigative Site San Cristóbal de La Laguna Santa Cruz De Tenerife 38320 Spain Details
Novartis Investigative Site Barakaldo Vizcaya 48903 Spain Details
Novartis Investigative Site Barcelona 08041 Spain Details
Novartis Investigative Site Las Palmas de Gran Canaria 35010 Spain Details
Novartis Investigative Site Madrid 28006 Spain Details
Novartis Investigative Site Madrid 28034 Spain Details
Novartis Investigative Site Madrid 28040 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Madrid 28046 Spain Details
Novartis Investigative Site Tarragona 43005 Spain Details
Novartis Investigative Site Lund SE-221 85 Sweden Details
Novartis Investigative Site Stockholm SE-171 76 Sweden Details
Novartis Investigative Site Uppsala SE-751 85 Sweden Details
Novartis Investigative Site Cardiff CF14 4XW United Kingdom Details
Novartis Investigative Site Oxford OX3 7LE United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field